Founded in 1997, The European Institute for Research and Development of Transplantation Strategies EUFETS AG is a specialist in services for innovative therapeutic approaches. Since 2001, EUFETS AG has been part of Fresenius Biotech GmbH. Fresenius Biotech GmbH is a company of the Fresenius health care group, focused on the development and marketing of biopharmaceuticals in the fields of oncology, immunology and regenerative medicine
Based on extensive expertise in molecular biology, virology and cell biology as well as an understanding of the regulatory prerequisites, the major goal of EUFETS AG is the support of clients developing innovative gene and cell therapies through development, testing and manufacturing services.
EUROFETS offers our customers a complete service spectrum from gene through clinical trial medication to in-market supply, providing every step from gene expression to cGMP manufacturing, including full project management support.